Figure - PMC

Skip to main content

An official website of the United States government

Here's how you know

Here's how you know

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

View full-text article in PMC

. 2022 Aug 14;28(30):4182–4200. doi: 10.3748/wjg.v28.i30.4182

Search in PMC
Search in PubMed
View in NLM Catalog
Add to search

©The Author(s) 2022. Published by Baishideng Publishing Group Inc. All rights reserved.

This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: https://creativecommons.org/Licenses/by-nc/4.0/

PMC Copyright notice

Cumulative incidences of hepatocellular carcinoma, decompensation, and death/transplantation in entire cohort. A: Cumulative incidence of hepatocellular carcinoma in the untreated, interferon-based treatment (IBT), and direct-acting antivirals (DAA) groups; B: Cumulative incidence of decompensation in the untreated, IBT, and DAA groups; C: Cumulative incidence of death/transplantation in the untreated, IBT, and DAA groups. DAA: Direct-acting antivirals; HCC: Hepatocellular carcinoma; IBT: Interferon-based treatment.